Doximity (DOCS) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Doximity · Health Care · ref. ETF XLV · 59 calls · price $30.55
What the company does: Doximity, Inc. operates a digital platform for medical professionals in the United States.
📈 Doximity (DOCS) stock price
$30.55-54.4% over range
Oct 14, 25low $18.01 · high $68.5Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
26% recommend buying · 19 analysts
📊 JPI status : Doximity has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 DOCS price target & analyst consensus — price $30.55
The price target · all analysts combined (17 targets)
Highest target · 1 firm of 17$47+53.8%
Median target · of 17 targets$26-14.9%
Lowest target · 2 firms of 17$18-41.1%
Current price$30.55
Where these 17 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
424%
$31 ↔ $47
Below
1376%
$18 ↔ $30
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Truist Securities — 65% of its targets hit on this sector (110 calls tested). It aims for $24 (-21 %), call made on August 14, 2026, maturing on August 14, 2027 (61 d ago).
The 3 reliable analysts
$24-21 %
The 14 other firms
$26.50-13 %
How to read it: the 3 reliable firms are not filtered by optimism — 1 aim above the price, 2 below, hence their $24 median. “The 14 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 19 ratings (last 6 months)
Strong Buy00%
Buy526%
Hold1263%
Sell211%
Strong Sell00%
Go deeper on the analysts
🎯 DOCS price target all
All 59 calls, one by one, with our verdict on each firm.
→ See all 59 targets, analyst by analyst💡 The best analysts on DOCS most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in DOCS? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Doximity? The JPI assistant answers using our backtest data.
📈 Doximity fundamentals: valuation, margins & growth › open the full page
P/E 35.9Net margin 25.5 %Revenue growth +7.3 %High P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2023
marg. 27 %
2024
Rev +13%Profit +31%
2025
Rev +20%Profit +51%
2026
Rev +13%Profit −12%
🔎 Detailed analyses
✅ Historical analyst reliability on DOCS
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| JP Morgan ↗ | 60% | -10.1% | 5 |
| Barclays ↗ | 50% | +21.5% | 2 |
| Jefferies ↗ | 50% | -18.8% | 2 |
| SVB Leerink | 33% | -26.1% | 3 |
| Baird ↗ | 33% | -26.2% | 6 |
| Canaccord Genuity ↗ | 29% | +8.4% | 7 |
| Morgan Stanley ↗ | 29% | -56.1% | 7 |
| Goldman Sachs ↗ | 25% | -0.2% | 4 |
| Raymond James ↗ | 20% | -36.6% | 10 |
| Needham ↗ | 18% | -25.0% | 11 |
See the other 6 firms
| Evercore ISI Group ↗ | 0% | -62.6% | 2 |
| Wells Fargo ↗ | 0% | -45.0% | 4 |
| Keybanc ↗ | 0% | -40.9% | 5 |
| Piper Sandler ↗ | 0% | -22.9% | 4 |
| Guggenheim ↗ | 0% | -18.0% | 2 |
| Berenberg ↗ | 0% | -15.7% | 2 |
📊 What $1,000 invested in Doximity would be worth › open the full page
In short — $1,000 invested in Doximity 10 years ago would be worth $370 today, i.e. -18%/yr on average. Best year: 2024 (+97%), worst: 2022 (-33%). Price performance, excluding dividends.
If I'd invested $1,000 in Doximity
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $376 | -62% |
| 3 years ago | $618 | -38% |
| 5 years ago | $370 | -63% |
Return by year (Doximity)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -52% | $479 (-52%) |
| 2025 | -22% | $376 (-62%) |
| 2024 | +97% | $740 (-26%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Doximity
Loading news…
📋 All analyst calls on DOCS
Filtered on — · ✕ show all
Evercore ISI Group ↗
Sep 29, 26
■ In-Line neutral · not a buy · 🎯$35
Price at call : $28.34 — gap to target +24%
Today : $30.55 — gap to target +15%
🎯 on DOCS : no call matured yet · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Sep 29, 27
matures : Sep 29, 27
Freedom Capital Markets
Sep 8, 26
■ Hold neutral · not a buy · 🎯$27
Price at call : $24.42 — gap to target +11%
Today : $30.55 — gap to target -12%
🎯 on DOCS : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 8, 27
matures : Sep 8, 27
■ Equal-Weight neutral · not a buy · 🎯$27
Price at call : $25.3 — gap to target +7%
Today : $30.55 — gap to target -12%
🎯 on DOCS : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Aug 21, 27
matures : Aug 21, 27
Truist Securities ↗
Aug 13, 26
■ Hold neutral · not a buy · 🎯$24
Price at call : $24.8 — gap to target -3%
Today : $30.55 — gap to target -21%
🎯 on DOCS : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
Wells Fargo ↗
Aug 10, 26
▼ Underweight · 🎯$18
Price at call : $25.63 — upside -30%
Today : $30.55 — upside -41%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
■ Neutral neutral · not a buy · 🎯$31
Price at call : $25.63 — gap to target +21%
Today : $30.55 — gap to target +1%
🎯 on DOCS : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Piper Sandler ↗
Aug 7, 26
▲ Overweight · 🎯$47
Price at call : $25.63 — upside +83%
Today : $30.55 — upside +54%
🎯 on DOCS : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Evercore ISI Group ↗
Aug 7, 26
■ In-Line neutral · not a buy · 🎯$40
Price at call : $27.4 — gap to target +46%
Today : $30.55 — gap to target +31%
🎯 on DOCS : no call matured yet · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
See the other 51 calls, newest to oldest
B of A Securities ↗
Jun 29, 26
▼ Underperform · 🎯$20
Price at call : $20.59 — upside -3%
Today : $30.55 — upside -35%
🎯 on DOCS : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
Goldman Sachs ↗
May 15, 26
■ Neutral neutral · not a buy · 🎯$24
Price at call : $19.58 — gap to target +23%
Today : $30.55 — gap to target -21%
🎯 on DOCS : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : May 15, 27
matures : May 15, 27
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $18.97 — gap to target +5%
Today : $30.55 — gap to target -35%
🎯 on DOCS : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : May 15, 27
matures : May 15, 27
Leerink Partners ↗
May 14, 26
▲ Outperform · 🎯$25
Price at call : $18.97 — upside +32%
Today : $30.55 — upside -18%
🎯 on DOCS : 0% (1 call matured) · 📊 on Health : 58.3% · +20.9% (12 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Hold neutral · not a buy · 🎯$19
Price at call : $18.97 — gap to target +0%
Today : $30.55 — gap to target -38%
🎯 on DOCS : no call matured yet · 📊 on Health : 48.3% · +10.7% (116 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Canaccord Genuity ↗
May 14, 26
▲ Buy · 🎯$30
Price at call : $18.97 — upside +58%
Today : $30.55 — upside -2%
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Neutral neutral · not a buy · 🎯$28
Price at call : $18.97 — gap to target +48%
Today : $30.55 — gap to target -8%
🎯 on DOCS : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Goldman Sachs ↗
May 14, 26
■ Neutral neutral · not a buy · 🎯$24
Price at call : $18.97 — gap to target +27%
Today : $30.55 — gap to target -21%
🎯 on DOCS : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Truist Securities ↗
May 14, 26
■ Hold neutral · not a buy · 🎯$19
Price at call : $18.97 — gap to target +0%
Today : $30.55 — gap to target -38%
🎯 on DOCS : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Wells Fargo ↗
May 14, 26
■ Equal-Weight neutral · not a buy · 🎯$18
Price at call : $18.01 — gap to target -0%
Today : $30.55 — gap to target -41%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
BMO Capital ↗
May 14, 26
■ Market Perform neutral · not a buy · 🎯$20
Price at call : $18.01 — gap to target +11%
Today : $30.55 — gap to target -35%
🎯 on DOCS : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Neutral neutral · not a buy · 🎯$26
Price at call : $18.01 — gap to target +44%
Today : $30.55 — gap to target -15%
🎯 on DOCS : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Morgan Stanley ↗
May 14, 26
▲ Overweight · 🎯$35
Price at call : $18.01 — upside +94%
Today : $30.55 — upside +15%
🎯 on DOCS : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Neutral neutral · not a buy
🎯 on DOCS : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Sector Weight neutral · not a buy
🎯 on DOCS : no call matured yet · 📊 on Health : 31.9% · -11.8% (47 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
▲ Buy · 🎯$27
Price at call : $18.01 — upside +50%
Today : $30.55 — upside -12%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Neutral neutral · not a buy · 🎯$18
Price at call : $18.01 — gap to target -0%
Today : $30.55 — gap to target -41%
🎯 on DOCS : no call matured yet · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Wells Fargo ↗
May 11, 26
▲ Overweight · 🎯$32
Price at call : $26.26 — upside +22%
Today : $30.55 — upside +5%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
Truist Securities ↗
Apr 20, 26
■ Hold neutral · not a buy · 🎯$29
Price at call : $24.39 — gap to target +19%
Today : $30.55 — gap to target -5%
🎯 on DOCS : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
B of A Securities ↗
Apr 16, 26
▲ Buy · 🎯$47
Price at call : $24.71 — upside +90%
Today : $30.55 — upside +54%
🎯 on DOCS : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Apr 16, 27
matures : Apr 16, 27
▲ Overweight · 🎯$30
Price at call : $22.66 — upside +32%
Today : $30.55 — upside -2%
🎯 on DOCS : no call matured yet · 📊 on Health : 31.9% · -11.8% (47 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Goldman Sachs ↗
Apr 9, 26
■ Neutral neutral · not a buy · 🎯$28
Price at call : $21.05 — gap to target +33%
Today : $30.55 — gap to target -8%
🎯 on DOCS : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Apr 9, 27
matures : Apr 9, 27
Evercore ISI Group ↗
Apr 8, 26
■ In-Line neutral · not a buy · 🎯$25
Price at call : $21.86 — gap to target +14%
Today : $30.55 — gap to target -18%
🎯 on DOCS : no call matured yet · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Freedom Capital Markets
Mar 18, 26
▲ Buy · 🎯$31
Price at call : $24.8 — upside +25%
Today : $30.55 — upside +1%
🎯 on DOCS : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Mar 18, 27
matures : Mar 18, 27
RBC Capital ↗
Mar 9, 26
▲ Outperform · 🎯$44
Price at call : $24.78 — upside +78%
Today : $30.55 — upside +44%
🎯 on DOCS : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Mar 9, 27
matures : Mar 9, 27
■ Neutral neutral · not a buy · 🎯$33
Price at call : $23.76 — gap to target +39%
Today : $30.55 — gap to target +8%
🎯 on DOCS : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Piper Sandler ↗
Feb 20, 26
▲ Overweight · 🎯$42
Price at call : $25.55 — upside +64%
Today : $30.55 — upside +37%
🎯 on DOCS : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
▲ Overweight · 🎯$38
Price at call : $25.96 — upside +46%
Today : $30.55 — upside +24%
🎯 on DOCS : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
■ Neutral neutral · not a buy · 🎯$34
Price at call : $27.24 — gap to target +25%
Today : $30.55 — gap to target +11%
🎯 on DOCS : no call matured yet · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Canaccord Genuity ↗
Feb 9, 26
▲ Buy · 🎯$34
Price at call : $27.24 — upside +25%
Today : $30.55 — upside +11%
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
Goldman Sachs ↗
Feb 9, 26
■ Neutral neutral · not a buy · 🎯$34
Price at call : $27.24 — gap to target +25%
Today : $30.55 — gap to target +11%
🎯 on DOCS : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
Wells Fargo ↗
Feb 6, 26
▲ Overweight · 🎯$45
Price at call : $27.5 — upside +64%
Today : $30.55 — upside +47%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
■ Neutral neutral · not a buy · 🎯$40
Price at call : $27.5 — gap to target +45%
Today : $30.55 — gap to target +31%
🎯 on DOCS : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Morgan Stanley ↗
Feb 6, 26
▲ Overweight · 🎯$49
Price at call : $27.73 — upside +77%
Today : $30.55 — upside +60%
🎯 on DOCS : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Piper Sandler ↗
Feb 6, 26
▲ Overweight · 🎯$40
Price at call : $27.73 — upside +44%
Today : $30.55 — upside +31%
🎯 on DOCS : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Truist Securities ↗
Feb 6, 26
▲ Buy · 🎯$37
Price at call : $27.73 — upside +33%
Today : $30.55 — upside +21%
🎯 on DOCS : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$55
Price at call : $27.73 — upside +98%
Today : $30.55 — upside +80%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$50
Price at call : $27.73 — upside +80%
Today : $30.55 — upside +64%
🎯 on DOCS : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Wells Fargo ↗
Jan 20, 26
▲ Overweight · 🎯$55
Price at call : $41.1 — upside +34%
Today : $30.55 — upside +80%
🎯 on DOCS : no call matured yet · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
▲ Overweight · 🎯$60
Price at call : $43.74 — upside +37%
Today : $30.55 — upside +96%
🎯 on DOCS : no call matured yet · 📊 on Health : 31.9% · -11.8% (47 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
Morgan Stanley ↗
Dec 15, 25
▲ Overweight · 🎯$65
Price at call : $44.65 — upside +46%
Today : $30.55 — upside +113%
🎯 on DOCS : no call matured yet · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
▲ Overweight · 🎯$63
Price at call : $45.04 — upside +40%
Today : $30.55 — upside +106%
🎯 on DOCS : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
Leerink Partners ↗
Feb 7, 25
▲ Outperform · 🎯$90
Price at call : $83.14 — upside +8%
Today : $30.55 — upside +195%
Expected +8% · Actual -67% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 0% (1 call matured) · 📊 on Health : 58.3% · +20.9% (12 calls)
-66.9%
stock -67% · XLV +7%
matured Feb 7, 26
Canaccord Genuity ↗
Aug 20, 24
▲ Buy · 🎯$40
Price at call : $36.23 — upside +10%
Today : $30.55 — upside +31%
Expected +10% · Actual +78% · Reason (≥ +15%) : ✓ Yes
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+77.6%
stock +78% · XLV -11%
matured Aug 20, 25
Leerink Partners ↗
Feb 26, 24
■ Market Perform neutral · not a buy · 🎯$32
Price at call : $27.99 — gap to target +14%
Today : $30.55 — gap to target +5%
🎯 on DOCS : 0% (1 call matured) · 📊 on Health : 58.3% · +20.9% (12 calls)
in progress (365j)
matures : Feb 25, 25
matures : Feb 25, 25
Canaccord Genuity ↗
Sep 5, 23
▲ Buy · 🎯$33
Price at call : $24.06 — upside +37%
Today : $30.55 — upside +8%
Expected +37% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
+48.4%
stock +48% · XLV +18%
matured Sep 4, 24
Canaccord Genuity ↗
Jun 7, 23
▲ Buy · 🎯$40
Price at call : $31.93 — upside +25%
Today : $30.55 — upside +31%
Expected +25% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-7.7%
stock -8% · XLV +13%
matured Jun 6, 24
Canaccord Genuity ↗
May 17, 23
▲ Buy · 🎯$40
Price at call : $33.31 — upside +20%
Today : $30.55 — upside +31%
Expected +20% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-15.8%
stock -16% · XLV +12%
matured May 16, 24
Canaccord Genuity ↗
Feb 10, 23
▲ Buy · 🎯$41
Price at call : $31.72 — upside +29%
Today : $30.55 — upside +34%
Expected +29% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-4.0%
stock -4% · XLV +9%
matured Feb 10, 24
Canaccord Genuity ↗
Aug 5, 22
▲ Buy · 🎯$42
Price at call : $40.61 — upside +3%
Today : $30.55 — upside +37%
Expected +3% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-15.2%
stock -15% · XLV +2%
matured Aug 5, 23
Canaccord Genuity ↗
Jul 19, 21
▲ Buy · 🎯$64
Price at call : $56.7 — upside +13%
Today : $30.55 — upside +109%
Expected +13% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on DOCS : 29% (7 calls matureds) · 📊 on Health : 52.7% · +5.8% (93 calls)
-24.6%
stock -25% · XLV +2%
matured Jul 19, 22
Frequently asked questions
Should I buy Doximity stock?
This isn't buy advice. For Doximity, the analyst consensus is "Hold", with an average price target of $26.00 (-15% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 60% of the time (5 calls tracked on Doximity). We show the numbers — you decide.
Is it too late to buy Doximity? How high can it go?
The most bullish analyst target on Doximity is $47.00 (+54% above today's price); the average is $26.00. That's the upside they see. Check how reliable those analysts have actually been on Doximity on our site before trusting it.
Is Doximity still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 16 analysts have a real record on Doximity, the best hitting 60% over 5 calls. Current consensus: "Hold". Make your call on data, not noise.
Will Doximity stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will DOCS stock recover (go back up)?
Should you invest in Doximity? The case for and against
The arguments for and against, one by one, from the numbers: why invest in DOCS (and why hesitate).
What has Doximity's past performance been?
Historical returns and a "how much if I had invested" calculator: DOCS performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX